Long-term immunogenicity of the new Vero cell-derived, inactivated Japanese encephalitis virus vaccine IC51: Six and 12 month results of a multicenter follow-up phase 3 study

Autor: Schuller, E., Jilma, B., Voicu, V., Golor, G., Kollaritsch, H., Kaltenböck, A., Klade, C., Tauber, E.
Zdroj: In Vaccine 2008 26(34):4382-4386
Databáze: ScienceDirect